Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Department of Pediatrics, University of California, La Jolla, San Diego, CA, USA.
Microbiome. 2023 May 27;11(1):119. doi: 10.1186/s40168-023-01566-2.
BACKGROUND: Alterations in gut microbiota have been implicated in HIV infection and cardiovascular disease. However, how gut microbial alterations relate to host inflammation and metabolite profiles, and their relationships with atherosclerosis, have not been well-studied, especially in the context of HIV infection. Here, we examined associations of gut microbial species and functional components measured by shotgun metagenomics with carotid artery plaque assessed by B-mode carotid artery ultrasound in 320 women with or at high risk of HIV (65% HIV +) from the Women's Interagency HIV Study. We further integrated plaque-associated microbial features with serum proteomics (74 inflammatory markers measured by the proximity extension assay) and plasma metabolomics (378 metabolites measured by liquid chromatography tandem mass spectrometry) in relation to carotid artery plaque in up to 433 women. RESULTS: Fusobacterium nucleatum, a potentially pathogenic bacteria, was positively associated with carotid artery plaque, while five microbial species (Roseburia hominis, Roseburia inulinivorans, Johnsonella ignava, Odoribacter splanchnicus, Clostridium saccharolyticum) were inversely associated with plaque. Results were consistent between women with and without HIV. Fusobacterium nucleatum was positively associated with several serum proteomic inflammatory markers (e.g., CXCL9), and the other plaque-related species were inversely associated with proteomic inflammatory markers (e.g., CX3CL1). These microbial-associated proteomic inflammatory markers were also positively associated with plaque. Associations between bacterial species (especially Fusobacterium nucleatum) and plaque were attenuated after further adjustment for proteomic inflammatory markers. Plaque-associated species were correlated with several plasma metabolites, including the microbial metabolite imidazole-propionate (ImP), which was positively associated with plaque and several pro-inflammatory markers. Further analysis identified additional bacterial species and bacterial hutH gene (encoding enzyme histidine ammonia-lyase in ImP production) associated with plasma ImP levels. A gut microbiota score based on these ImP-associated species was positively associated with plaque and several pro-inflammatory markers. CONCLUSION: Among women living with or at risk of HIV, we identified several gut bacterial species and a microbial metabolite ImP associated with carotid artery atherosclerosis, which might be related to host immune activation and inflammation. Video Abstract.
背景:肠道微生物群的改变与 HIV 感染和心血管疾病有关。然而,肠道微生物改变与宿主炎症和代谢物谱的关系,以及它们与动脉粥样硬化的关系,尚未得到很好的研究,特别是在 HIV 感染的背景下。在这里,我们通过宏基因组学检测了 320 名 HIV 感染者或 HIV 高危女性(65%为 HIV+)的肠道微生物物种和功能成分与颈动脉斑块之间的相关性,这些女性来自妇女艾滋病病毒研究机构间网络(Women's Interagency HIV Study)。我们进一步整合了斑块相关微生物特征与血清蛋白质组学(通过接近延伸测定法测量的 74 种炎症标志物)和血浆代谢组学(通过液相色谱串联质谱法测量的 378 种代谢物),以研究多达 433 名女性颈动脉斑块与这些标志物的关系。
结果:具有潜在致病性的梭杆菌属(Fusobacterium nucleatum)与颈动脉斑块呈正相关,而 5 种微生物(罗氏菌属(Roseburia)、罗氏真杆菌(Roseburia inulinivorans)、伊格那凡氏菌(Johnsonella ignava)、奥多比氏菌(Odoribacter splanchnicus)、解糖梭菌(Clostridium saccharolyticum))与斑块呈负相关。在有或没有 HIV 的女性中,结果都是一致的。梭杆菌属(Fusobacterium nucleatum)与几种血清蛋白质组学炎症标志物(如 CXCL9)呈正相关,而其他与斑块相关的物种与蛋白质组学炎症标志物(如 CX3CL1)呈负相关。这些与微生物相关的蛋白质组学炎症标志物也与斑块呈正相关。在进一步调整蛋白质组学炎症标志物后,细菌种类(特别是梭杆菌属)与斑块之间的关联减弱。与斑块相关的物种与几种血浆代谢物相关,包括微生物代谢物咪唑丙酸(ImP),ImP 与斑块和几种促炎标志物呈正相关。进一步的分析确定了与血浆 ImP 水平相关的其他细菌物种和细菌 hutH 基因(编码 ImP 产生中的组氨酸氨裂解酶)。基于这些与 ImP 相关的物种的肠道微生物群评分与斑块和几种促炎标志物呈正相关。
结论:在有或有 HIV 感染风险的女性中,我们确定了几种与颈动脉粥样硬化相关的肠道细菌物种和微生物代谢物 ImP,这可能与宿主免疫激活和炎症有关。
Arterioscler Thromb Vasc Biol. 2022-8
J Clin Endocrinol Metab. 2024-1-18
Microorganisms. 2025-4-3
Front Endocrinol (Lausanne). 2025-2-17
Arterioscler Thromb Vasc Biol. 2022-8
J Crohns Colitis. 2022-7-14
Rheumatology (Oxford). 2021-12-24